Induction of β-Glucuronidase Release by Cytostatic Agents in Small Tumors-Reference-Cited by-同舟云学术

Induction of β-Glucuronidase Release by Cytostatic Agents in Small Tumors

Published:2012-10-11 Issue:11 Volume:9 Page:3277-3285
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

F. Antunes Inês¹,Haisma Hidde J.²,Elsinga Philip H.¹,Di Gialleonardo Valentina¹,Waarde Aren van¹,Willemsen Antoon T. M.¹,Dierckx Rudi A.¹,de Vries Erik F. J.¹

Affiliation:

1. Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands

2. Department of Pharmaceutical Gene Modulation, University Center for Pharmacy, University of Groningen, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp300327w

Reference21 articles.

1. Beta-Glucuronidase-Mediated Drug Release

2. A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer

3. Anti-tumour activity and toxicity of the new prodrug9-aminocamptothecin glucuronide (9ACG) in mice

4. Pronounced Antitumor Efficacy by Extracellular Activation of a Doxorubicin-Glucuronide Prodrug After Adenoviral Vector-Mediated Expression of a Human Antibody-Enzyme Fusion Protein

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FIS103, a Novel SULT1A1-dependent Prodrug, Demonstrates Potent Antitumor Activity in Renal Cell Carcinoma;2024-03-26

2. Arctigenin Prevents Retinal Edema in a Murine Retinal Vein Occlusion Model;Biological and Pharmaceutical Bulletin;2023-03-01

3. Relationship between the in vitro efficacy, pharmacokinetics and in vivo efficacy of curcumin;Biochemical Pharmacology;2022-11

4. Glucuronides: From biological waste to bio-nanomedical applications;Journal of Controlled Release;2022-09

5. Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives;Theranostics;2022